{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T02:08:18Z","timestamp":1725674898577},"publisher-location":"Basel","reference-count":52,"publisher":"Birkh\u00e4user Basel","isbn-type":[{"type":"print","value":"9783034873994"},{"type":"electronic","value":"9783034873970"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1993]]},"DOI":"10.1007\/978-3-0348-7397-0_11","type":"book-chapter","created":{"date-parts":[[2012,4,12]],"date-time":"2012-04-12T13:11:31Z","timestamp":1334236291000},"page":"125-143","source":"Crossref","is-referenced-by-count":0,"title":["Factor XII Activation and Inhibition in Inflammation"],"prefix":"10.1007","author":[{"given":"Robert W.","family":"Colman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"11_CR1","doi-asserted-by":"crossref","first-page":"13666","DOI":"10.1016\/S0021-9258(17)38776-8","volume":"260","author":"DE Cool","year":"1985","unstructured":"Cool DE, Edgell C-J, Louie GV, Zoller MJ, Brayer GD, MacGillivray RT. (1985) Characterization of human blood coagulation factor XII cDNA: Prediction of the primary structure of factor XII and the tertiary structure of betafactor Xlla. J Biol Chem 260: 13666\u201313676.","journal-title":"J Biol Chem"},{"key":"11_CR2","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1016\/S0021-9258(20)79699-7","volume":"225","author":"M Silverberg","year":"1980","unstructured":"Silverberg M, Dunn JT, Garen L, Kaplan AP. (1980) Autoactivation of human Hageman factor: Demonstration using a synthetic substrate. J Biol Chem 225: 7281\u20137286.","journal-title":"J Biol Chem"},{"key":"11_CR3","doi-asserted-by":"crossref","first-page":"8215","DOI":"10.1016\/S0021-9258(20)82051-1","volume":"258","author":"G Tans","year":"1983","unstructured":"Tans G, Rosing J, Griffin JH. (1983) Sulfatide-dependent autoactivation of human blood coagulation factor XII (Hageman Factor). J Biol Chem 258: 8215\u20138222.","journal-title":"J Biol Chem"},{"key":"11_CR4","doi-asserted-by":"crossref","first-page":"10140","DOI":"10.1016\/S0021-9258(18)61089-0","volume":"262","author":"RA Pixley","year":"1987","unstructured":"Pixley RA, Stumpo LG, Birkmeyer K, Silver L, Colman RW. (1987) A monoclonal antibody recognizing an icosapeptide sequence in the heavy chain of human factor XII inhibits surface catalyzed activation. J Biol Chem 262: 10140\u201310145.","journal-title":"J Biol Chem"},{"key":"11_CR5","doi-asserted-by":"publisher","first-page":"5831","DOI":"10.1021\/bi00645a030","volume":"16","author":"K Kurachi","year":"1977","unstructured":"Kurachi K, Davie EW. (1977) Activation of human factor XI (plasma thromboplastin antecedent) by factor XIla (activated Hageman factor). Biochem 16: 5831\u20135839.","journal-title":"Biochem"},{"key":"11_CR6","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1172\/JCI108898","volume":"60","author":"RE Thompson","year":"1977","unstructured":"Thompson RE, Mandle R Jr, Kaplan AP. (1977) Association of factor XI and high molecular weight kininogen in human plasma. J Clin Invest 60: 1376\u20131380.","journal-title":"J Clin Invest"},{"key":"11_CR7","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1172\/JCI111319","volume":"73","author":"CF Scott","year":"1984","unstructured":"Scott CF, Silver LD, Schapira M, Colman RW. (1984) Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity: Evidence that this molecule exists as a procofactor. J Clin Invest 73: 954\u2013962.","journal-title":"J Clin Invest"},{"key":"11_CR8","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1021\/bi00357a018","volume":"25","author":"K Fujikawa","year":"1986","unstructured":"Fujikawa K, Chung DW, Hendrickson LE, Davie EW. (1986) Amino acid sequence of human factor XI, a blood coagulation factor with four tandem repeats that are highly homologous with plasma prekallikrein. Biochem 25: 2417\u20132424.","journal-title":"Biochem"},{"key":"11_CR9","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1021\/bi00222a008","volume":"30","author":"BA Mcmullen","year":"1991","unstructured":"McMullen BA, Fujikawa K, Davie EW. (1991) Location of the disulfide bonds in human coagulation factor XI: The presence of tandem apple domains. Biochem 30: 2056\u20132060.","journal-title":"Biochem"},{"key":"11_CR10","doi-asserted-by":"publisher","first-page":"4179","DOI":"10.1073\/pnas.73.11.4179","volume":"73","author":"RJ Mandle","year":"1976","unstructured":"Mandle RJ, Colman RW, Kaplan AP. (1976) Identification of prekallikrein and high molecular weight kininogen as a complex in human plasma. Proc Natl Acad Sci USA 73: 4179\u20134183.","journal-title":"Proc Natl Acad Sci USA"},{"key":"11_CR11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.7326\/0003-4819-77-2-205","volume":"77","author":"P Wong","year":"1972","unstructured":"Wong P, Colman RW, Talamo RC, Babior BM. (1972) Kallikrein-bradykinin system in chronic alcoholic liver disease. Ann Intern Med 77: 205\u2013209.","journal-title":"Ann Intern Med"},{"key":"11_CR12","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1021\/bi00357a017","volume":"25","author":"DW Chung","year":"1986","unstructured":"Chung DW, Fujikawa K, McMullen BA, Davie EW. (1986) Human plasma prekallikrein, a zymogen to a serine protease that contains four tandem repeats. Biochem 25: 2410\u20132417.","journal-title":"Biochem"},{"key":"11_CR13","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1021\/bi00222a007","volume":"30","author":"BA Mcmullen","year":"1991","unstructured":"McMullen BA, Fujikawa K, Davie EW. (1991) Location of the disulfide bonds in human plasma prekallikrein: The presence of four novel apple domains in the amino terminal portion of the molecule. Biochem 30: 2050\u20132056.","journal-title":"Biochem"},{"key":"11_CR14","unstructured":"Page JD, Colman RW. (1991) Localization of distinct functional domains on prekallikrein for interaction with both high molecular weight kininogen and activated factor XII in a 28 kDa fragment (amino acids 141\u2013371). J Blot Chem 266: 81438148."},{"key":"11_CR15","volume-title":"J Immunol 104: 574-581","author":"I Gigli","year":"1970","unstructured":"Gigli I, Mason JW, Colman RW, Austen KF. (1970) Interaction of plasma kallikrein with Cl-inhibitor. J Immunol 104: 574\u2013581."},{"key":"11_CR16","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1021\/bi00513a006","volume":"20","author":"M Schapira","year":"1981","unstructured":"Schapira M, Scott CF, Colman RW. (1981) Protection of human plasma kallikrein from inactivation of Cl-inhibitor and other protease inhibitors. The role of high molecular weight kininogen. Biochem 20: 2738\u20132743.","journal-title":"Biochem"},{"key":"11_CR17","doi-asserted-by":"crossref","first-page":"12020","DOI":"10.1016\/S0021-9258(19)86421-9","volume":"245","author":"DM Kerbiriou","year":"1979","unstructured":"Kerbiriou DM, Griffin JH. (1979) Human high molecular weight kininogen: Studies of structure-function relationships and of proteolysis of the molecule occurring during contact activation of plasma. J Biol Chem 245: 12020\u201312027.","journal-title":"J Biol Chem"},{"key":"11_CR18","doi-asserted-by":"crossref","first-page":"8610","DOI":"10.1016\/S0021-9258(17)39516-9","volume":"260","author":"N Kitamura","year":"1985","unstructured":"Kitamura N, Kitagawa H, Fukushima D, et al (1985) Structural organization of the kininogen gene and a model for its evolution. J Biol Chem 260: 8610\u20138617.","journal-title":"J Biol Chem"},{"key":"11_CR19","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1172\/JCI112472","volume":"77","author":"AH Schmaler","year":"1986","unstructured":"Schmaler AH, Bradford H, Silver LD, et al (1986) High molecular weight kininogen is an inhibitor of platelet calpain. J Clin Invest 77: 1565\u20131573.","journal-title":"J Clin Invest"},{"key":"11_CR20","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1182\/blood.V77.3.500.500","volume":"77","author":"RN Puri","year":"1991","unstructured":"Puri RN, Zhou F, Hu CJ, Colman RF, Colman RW. (1991) High molecular weight kininogen inhibits thrombin-induced platelet aggregation and cleavage of aggregin by inhibiting binding of thrombin to platelets. Blood 77: 500\u2013507.","journal-title":"Blood"},{"key":"11_CR21","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1084\/jem.147.2.488","volume":"147","author":"RE Thompson","year":"1978","unstructured":"Thompson RE, Mandle R Jr, Kaplan AP. (1978) Characterization of human high molecular weight kininogen: Procoagulant activity associated with the light chain of kinin-free high molecular weight kininogen. J Exp Med 147: 488\u2013499.","journal-title":"J Exp Med"},{"key":"11_CR22","doi-asserted-by":"crossref","first-page":"11651","DOI":"10.1016\/S0021-9258(18)60859-2","volume":"262","author":"JF Tait","year":"1987","unstructured":"Tait JF, Fujikawa K. (1987) Primary structure requirements for the binding of human high molecular weight kininogen to plasma prekallikrein and factor XI. J Biol Chem 262: 11651\u201311656.","journal-title":"J Biol Chem"},{"key":"11_CR23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/pro.5560010115","volume":"1","author":"RA Dela","year":"1992","unstructured":"DeLa Cadena RA, Colman RW. (1992) The sequence HGLGHGHEQQHGLGHGH in the light chain of high molecular weight kininogen serves as a primary structural feature for zinc-dependent binding to an anionic surface. Prot Sci 1: 151\u2013160.","journal-title":"Prot Sci"},{"key":"11_CR24","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1093\/oxfordjournals.jbchem.a133339","volume":"89","author":"K Mori","year":"1981","unstructured":"Mori K, Nagasawa S. (1981) Studies on human high molecular weight (HMW) kininogen. Il. Structural change of HMW kininogen by the action of human plasma kallikrein. J Biochem 89: 1465\u20131473.","journal-title":"J Biochem"},{"key":"11_CR25","doi-asserted-by":"crossref","first-page":"10856","DOI":"10.1016\/S0021-9258(19)85161-X","volume":"260","author":"CF Scott","year":"1985","unstructured":"Scott CF, Silver LD, Purdon AD, Colman RW. (1985) Cleavage of human high molecular weight kininogen by factor Xla in vitro: Effect on structure and function. J Biol Chem 260: 10856\u201310863.","journal-title":"J Biol Chem"},{"key":"11_CR26","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/S0021-9258(18)89653-3","volume":"260","author":"RA Pixley","year":"1985","unstructured":"Pixley RA, Schapira M, Colman RW. (1985) The regulation of human factor Xlla by plasma proteinase inhibitors. J Biol Chem 260: 1723\u20131729.","journal-title":"J Biol Chem"},{"key":"11_CR27","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1172\/JCI111360","volume":"73","author":"A Agostini","year":"1984","unstructured":"De Agostini A, Lijnen HR, Pixley RA, Colman RW, Schapira M. (1984) Inactivation of factor XII active fragment in normal plasma: Predominant role of Cl-inhibitor. J Clin Invest 73: 1542\u20131549.","journal-title":"J Clin Invest"},{"key":"11_CR28","first-page":"882","volume":"104","author":"AH Schmaier","year":"1984","unstructured":"Schmaier AH, Gustafson E, Idell S, Colman RW. (1984) Plasma prekallikrein assay: Reversible inhibition of Cl-inhibitor by chloroform and its use in measuring prekallikrein in different mammalian species. J Lab Clin Med 104: 882\u2013892.","journal-title":"J Lab Clin Med"},{"key":"11_CR29","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1172\/JCI110524","volume":"69","author":"CF Scott","year":"1982","unstructured":"Scott CF, Schapira M, James HL, Cohen AB, Colman RW. (1982) Inactivation of factor Xla by plasma protease inhibitors: Predominant role of a1-protease inhibitor and protective effect of high molecular weight kininogen. J Clin Invest 69: 844\u2013852.","journal-title":"J Clin Invest"},{"key":"11_CR30","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1749-6632.1989.tb22493.x","volume":"556","author":"RW Colman","year":"1989","unstructured":"Colman RW, Scott CF, Pixley RA, DeLa Cadena RA. (1989) Effect of heparin on the inhibition of the contact system enzymes. Ann NYAcad Sci USA 556: 95\u2013103.","journal-title":"Ann NYAcad Sci USA"},{"key":"11_CR31","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1084\/jem.153.3.665","volume":"153","author":"B Ghebrehiwet","year":"1981","unstructured":"Ghebrehiwet B, Silverberg M, Kaplan AP. (1981) Activation of the classical pathway of complement by Hageman factor fragment. J Exp Med 153: 665\u2013676.","journal-title":"J Exp Med"},{"key":"11_CR32","doi-asserted-by":"crossref","first-page":"545","DOI":"10.7326\/0003-4819-73-4-545","volume":"73","author":"JW Mason","year":"1970","unstructured":"Mason JW, Kleeberg U, Dolan P, Colman RW. (1970) Plasma kallikrein and Hageman factor in gram negative bacteremia. Ann Intern Med 73: 545\u2013551.","journal-title":"Ann Intern Med"},{"key":"11_CR33","first-page":"325","volume":"26","author":"JW Mason","year":"1971","unstructured":"Mason JW, Colman RW. (1971) The role of Hageman factor in disseminated intravascular coagulation induced by septicemia, neoplasia or liver disease. Thromb Diath Haemorrh 26: 325.","journal-title":"Thromb Diath Haemorrh"},{"key":"11_CR34","first-page":"539","volume":"143","author":"TF O\u2019Donnell","year":"1976","unstructured":"O\u2019Donnell TF, Clowes GH, Talamo RC, Colman RW. (1976) Kinin activation in the blood of patients with sepsis. Surg Gynecol Obstet 143: 539\u2013545.","journal-title":"Surg Gynecol Obstet"},{"key":"11_CR35","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1172\/JCI108938","volume":"61","author":"RW Colman","year":"1978","unstructured":"Colman RW, Edelman R, Scott CF, Gilman RH. (1978) Plasma kallikrein activation and inhibition during typhoid fever. J Clin Invest 61: 287\u2013296.","journal-title":"J Clin Invest"},{"key":"11_CR36","first-page":"270","volume":"112","author":"AC Carvalho","year":"1988","unstructured":"Carvalho AC, DeMarinis S, Scott CF, Silver LD, Schmaier AH, Colman RW. (1988) Activation of the contact system of plasma proteolysis in the adult respiratory distress syndrome. J Lab Clin Med 112: 270\u2013277.","journal-title":"J Lab Clin Med"},{"key":"11_CR37","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1056\/NEJM198804213181603","volume":"318","author":"AK Rao","year":"1988","unstructured":"Rao AK, Schapira M, Clements ML, et al (1988) A prospective study of platelets and plasma proteolytic systems during the early stages of Rocky Mountain spotted fever. N Engl J Med 318: 1021\u20131028.","journal-title":"N Engl J Med"},{"key":"11_CR38","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1182\/blood.V72.6.1841.1841","volume":"72","author":"JH Nuijens","year":"1988","unstructured":"Nuijens JH, Huijbregts CC, Eerenberg-Belmer AJ, et al (1988) Quantification of plasma factor Xlla-C1-inhibitor and kallikrein-C1-inhibitor complexes in sepsis. Blood 72: 1841\u20131848.","journal-title":"Blood"},{"key":"11_CR39","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1182\/blood.V77.12.2660.2660","volume":"77","author":"N Kaufman","year":"1991","unstructured":"Kaufman N, Page JD, Pixley RA, Schein R, Schmaier AH, Colman RW. (1991) Alpha-2-macroglobulin-kallikrein complexes detect contact system activation in hereditary angioedema and human sepsis. Blood 77: 2660\u20132667.","journal-title":"Blood"},{"key":"11_CR40","first-page":"346a","volume":"38","author":"RA Dela","year":"1990","unstructured":"DeLa Cadena RA, Suffredini AF, Kaufman N, Parrillo JE, Colman RW. (1990) Activation of the kallikrein-kinin system after endotoxin administration to normal human volunteers. Clin Res 38: 346a.","journal-title":"Clin Res"},{"key":"11_CR41","first-page":"159","volume-title":"New Aspects of Trasylol Therapy-The Lund in Shock.","author":"A Weisser","year":"1973","unstructured":"Weisser A, Clowes GH, Colman RW, Talamo RC. (1973) Sepsis and endotoxemia in pigs: A comparison of mortality and pathophysiology. In: New Aspects of Trasylol Therapy-The Lund in Shock. ( Haberland GL, Lewis DH, eds.) Schattauer-Verlag: New York, 159\u2013174."},{"key":"11_CR42","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1056\/NEJM198309223091203","volume":"309","author":"MC Owen","year":"1983","unstructured":"Owen MC, Brennan SO, Lewis JH, Carrell RW. (1983) Mutation of antitrypsin to antithrombin: Alpha-1-antitrypsin Pittsburgh (358 Met-Arg) abated bleeding disorder. N Eng\/ J Med 309: 694\u2013698.","journal-title":"N Eng\/ J Med"},{"key":"11_CR43","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1172\/JCI112346","volume":"77","author":"CF Scott","year":"1986","unstructured":"Scott CF, Carrell RW, Glaser CB, Kueppers F, Lewis JH, Colman RW. (1986) Alpha-1-antitrypsin Pittsburgh: A potent inhibitor of human plasma factor IXa, kallikrein and factor Xllf. J Clin Invest 77: 631\u2013634.","journal-title":"J Clin Invest"},{"key":"11_CR44","first-page":"418","volume":"130","author":"RW Colman","year":"1988","unstructured":"Colman RW, Flores DN, DeLa Cadena RA, et al (1988) Recombinant alpha-1- antitrypsin Pittsburgh attenuates experimental gram negative septicemia. Am J Pathol 130: 418\u2013426.","journal-title":"Am J Pathol"},{"key":"11_CR45","first-page":"897","volume":"140","author":"RA Pixley","year":"1992","unstructured":"Pixley RA, DeLa Cadena R, Page JD, et al (1992) Activation of the contact system in lethal hypotensive bacteremia in a baboon model. Am J Pathol 140: 897\u2013906.","journal-title":"Am J Pathol"},{"key":"11_CR46","first-page":"433a","volume":"76","author":"RA Pixley","year":"1990","unstructured":"Pixley RA, DeLa Cadena RA, Kaufman N, et al (1990) In vivo use of a monoclonal antibody to factor XII (Hageman factor) in a lethal hypotensive septicemic baboon model. Blood 76: 433a.","journal-title":"In vivo use of a monoclonal antibody to factor XII (Hageman factor) in a lethal hypotensive septicemic baboon model. Blood"},{"key":"11_CR47","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1182\/blood.V69.1.324.324","volume":"68","author":"YT Wachtfogel","year":"1987","unstructured":"Wachtfogel YT, Kucich U, Greenplate G, et al (1987) Human neutrophil degranulation during extracorporeal circulation. Blood 68: 324\u2013330.","journal-title":"Blood"},{"key":"11_CR48","first-page":"49","volume-title":"Pathophysioloqy and Techniques of Cardiopulmonary Bypass","author":"DE Chenoweth","year":"1983","unstructured":"Chenoweth DE. (1983) Complement activation during cardiopulmonary bypass. In: Pathophysioloqy and Techniques of Cardiopulmonary Bypass. ( Utley JR, Ed.) Williams & Wilkins: Baltimore, p. 49."},{"key":"11_CR49","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1172\/JCI111126","volume":"72","author":"YT Wachtfogel","year":"1983","unstructured":"Wachtfogel YT, Kucich U, James HL, et al. (1983) Human plasma kallikrein releases neutrophil elastase during blood coagulation. J Clin Invest 72: 1672.","journal-title":"J Clin Invest"},{"key":"11_CR50","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1182\/blood.V73.2.468.468","volume":"73","author":"YT Wachtfogel","year":"1989","unstructured":"Wachtfogel YT, Harpel PC, Edmunds LH Jr, Colman RW. (1989) Formation of Cl s-Cl -inhibitor, kallikrein-C1\u20131 nhibitor, and plasmin a2-plasmin complexes during cardiopulmonary bypass. Blood 73: 468\u2013471.","journal-title":"Blood"},{"key":"11_CR51","doi-asserted-by":"crossref","unstructured":"Wachtfogel YT, Kucich U, Hack CE, et al. (1992) Aprotinin inhibits the contact, neutrophil and platelet activation systems during simulated extracorporeal bypass. J Thorac Cardiovasc Surg (in press).","DOI":"10.1016\/S0022-5223(19)33735-3"},{"key":"11_CR52","unstructured":"Wachtfogel YT, Hack CE, Nuijens JH, et al. (1991) Selective inhibitors of the contact pathway of intrinsic coagulation after the release of human neutrophil elastase during simulated extracorporeal circulation. Proc Cardiovasc Sci Technol Conference: 156."}],"container-title":["Proteases, Protease Inhibitors and Protease-Derived Peptides"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-0348-7397-0_11.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T14:20:21Z","timestamp":1641997221000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-0348-7397-0_11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993]]},"ISBN":["9783034873994","9783034873970"],"references-count":52,"URL":"https:\/\/doi.org\/10.1007\/978-3-0348-7397-0_11","relation":{},"subject":[],"published":{"date-parts":[[1993]]}}}